A collaboration between the USC Stevens Center and leadership from IntelliMicro Medical Co. and Golden Eye Bionics took place to discuss the commercialization of medical devices.
From research studying how to change our inability to recover hearing ability to research showing underrepresented minority groups in Alzheimer’s neuroimaging research, innovation was thriving in the month of August.
This year, various USC research has shed insight on the subject of vaccines, their importance, and how they can help prevent serious and deadly diseases and illnesses.
USC-supported startup Regenerative Patch Technologies (RPT) was awarded an estimated $12.4 million from the California Institute for Regenerative Medicine (CIRM), a state institute that supports research to address unmet medical needs.
With temperatures on the rise, USC-led research and innovation continue to follow suit.
One of USC’s core values is to create a greener campus and planet, commit to making sustainability important, and integrate the core values across the University. By maximizing positive behaviors, USC believes the community can support a world where all species survive and thrive. In 2022, USC Research and Innovation introduced the $1.25M President’s Sustainability Initiative
From executing the largest IP transfer of its kind for commercialization to launching a prototype for testing on the International Space Station, USC continues to maintain its ranking as one of the nation’s top universities
In May, the USC Office of Research and Innovation and USC Stevens Center proudly hosted a digital transformation roundtable discussion on campus. The event was led by Techstars and the Alliance for SoCal Innovation and featured USC thought leaders committed to advancing research and innovation in the new digital era.
From studies focusing on AI discoveries to inspiring commencement stories about USC graduates whose postgrad steps include working for Meta or training for the Olympics, there were several inspiring discoveries made in the month of May.
In honor of Brain Cancer Awareness Month, USC Stevens Center for Innovation is proud to announce that we have executed an exclusive global IP licensing agreement with NeOnc Technologies for an enhanced method of delivering novel pharma therapeutics to the brain.
USC Stevens Center for Innovation
1150 South Olive Street, Suite 2300
Los Angeles, CA, 90015